Divi's Laboratories (NSE:DIVISLAB) Forward Dividend Yield %: 0.44% (As of Jun. 25, 2026)


NSE:DIVISLAB Divi's Laboratories Ltd NSE:DIVISLAB
94 GF Score
Price ₹6,753.50
GF Value ₹6,729.63
Valuation Fairly Valued
! 5 Warning Signs
View Full Analysis

What is Divi's Laboratories Forward Dividend Yield %?

Divi's Laboratories NSE:DIVISLAB +0.10% 94 Forward Dividend Yield % is 0.44% as of Jun. 25, 2026. GuruFocus rates NSE:DIVISLAB with a GF Score™ of 94/100 and a GF Value™ of ₹6,729.63 (Fairly Valued). The stock has 5 warning signs investors should review. Among 504 Drug Manufacturers companies, Divi's Laboratories ranks worse than 84.92% on this metric.

As of today (2026-06-25), the Forward Annual Dividend Yield of Divi's Laboratories is 0.44%.

As of today (2026-06-25), the Trailing Annual Dividend Yield of Divi's Laboratories is 0.44%.

NSE:DIVISLAB's Forward Dividend Yield % is ranked worse than
84.92% of 504 companies
in the Drug Manufacturers industry
Industry Median: 2.095 vs NSE:DIVISLAB: 0.44

Divi's Laboratories's Dividends per Share for the three months ended in Mar. 2026 was ₹0.00.

During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of Divi's Laboratories was 71.00% per year. The lowest was -20.60% per year. And the median was 26.00% per year.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.


Divi's Laboratories  (NSE:DIVISLAB) Forward Dividend Yield % Explanation

Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.

Dividends may also qualify a lower tax rate for investors.

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

You can find the stocks that owned most by Gurus here. Or you can check out Warren Buffett's highest dividend stocks here.


Divi's Laboratories Forward Dividend Yield % Related Terms


NSE:DIVISLAB vs ZTS: Forward Dividend Yield % Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Divi's Laboratories's Forward Dividend Yield %, along with its competitors' market caps and Forward Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Divi's Laboratories Forward Dividend Yield % vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Divi's Laboratories's Forward Dividend Yield % distribution charts can be found below:

* The bar in red indicates where Divi's Laboratories's Forward Dividend Yield % falls into.


NSE:DIVISLAB
94GF Score
Divi's Laboratories Ltd NSE:DIVISLAB
Forward Dividend Yield % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Divi's Laboratories Forward Dividend Yield % Calculation

Dividend Yield measures how much a company pays out in dividends each year relative to its share price.

Divi's Laboratories Recent Full-Year* Dividend History

Amount Ex-date Record Date Pay Date Type Frequency Forex Rate
INR 30.0000002025-07-252025-07-252025-08-14Cash DividendannuallyINR:INR 1.000000

* GuruFocus has an internal rule that if the most recent dividend payment frequency is at least 4 times a year, then the full year will be calculated according to the frequency of payment or the one-year time frame, whichever is stricter.
* GuruFocus converts dividend currency to local traded share price currency in order to calculate dividend yield. Please refer to the last column "Forex Rate" in the above table.

Divi's Laboratories's Forward Annual Dividend Yield (%) for Today is calculated as

Forward Annual Dividend Yield=Forward Full Year Dividend/Current Share Price
=30/6753.50
=0.44 %

Current Share Price is ₹6753.50.
Divi's Laboratories's Dividends per Share for the forward twelve months is calculated as ₹30 * 1 = ₹30.

Divi's Laboratories's Trailing Annual Dividend Yield (%) for Today is calculated as

Trailing Annual Dividend Yield=Most Recent Full Year Dividend/Current Share Price
=30/6753.50
=0.44 %

Current Share Price is ₹6753.50.
Divi's Laboratories's Dividends per Share for the trailing twelve months (TTM) ended in Today is ₹30.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Forward Dividend Yield % of 0.44% mean?
Divi's Laboratories (NSE:DIVISLAB) has a Forward Dividend Yield % of 0.44% as of Jun. 25, 2026. Forward dividend yield is the ratio of company's expected dividends to the share price. View historical data on Divi's Laboratories and its competitors. According to the industry distribution chart, Divi's Laboratories ranks #428 out of 504 companies in the Drug Manufacturers industry, placing it in the top 84.9%.
Is Divi's Laboratories' Forward Dividend Yield % too high?
Divi's Laboratories' current Forward Dividend Yield % is 0.44%. The Drug Manufacturers industry median Forward Dividend Yield % is 2.10. Divi's Laboratories' value of 0.44% is 79% below this industry median. Based on the distribution chart, Divi's Laboratories ranks #428 out of 504 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Divi's Laboratories has a GF Score™ of 94/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Divi's Laboratories' Forward Dividend Yield % compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Divi's Laboratories ranks #428 out of 504 companies for Forward Dividend Yield %. This places Divi's Laboratories in the lower half of its industry. The industry median Forward Dividend Yield % is 2.10. Divi's Laboratories' value of 0.44% is 79% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Forward Dividend Yield % for a Drug Manufacturers company?
The median Forward Dividend Yield % among Drug Manufacturers companies is 2.10, based on 504 companies in the industry. Companies in the top quartile (top 25%) have a Forward Dividend Yield % significantly above this median, while those in the bottom quartile fall well below. However, Forward Dividend Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Divi's Laboratories's current Forward Dividend Yield % of 0.44% is 79% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Forward Dividend Yield % mean?
A high Forward Dividend Yield % can signal that a stock is expensive relative to its fundamentals. Forward dividend yield is the ratio of company's expected dividends to the share price. View historical data on Divi's Laboratories and its competitors. For the Drug Manufacturers industry, the median Forward Dividend Yield % is 2.10 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Divi's Laboratories's current Forward Dividend Yield % is 0.44%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Divi's Laboratories stock overvalued right now?
Based on GuruFocus' analysis, Divi's Laboratories (NSE:DIVISLAB) is currently considered Fairly Valued. The stock's GF Value™ is ₹6,729.63, compared to a current price of ₹6,753.50 — trading 0.4% above its estimated fair value. The current Forward Dividend Yield % is 0.44% and 79% below the Drug Manufacturers industry median of 2.10. Divi's Laboratories' overall GF Score™ is 94/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Forward Dividend Yield % calculated?
Forward Dividend Yield % is calculated from a company's financial statements. For Divi's Laboratories (NSE:DIVISLAB), the current Forward Dividend Yield % is 0.44% as of Jun. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Divi's Laboratories (NSE:DIVISLAB) Overvalued in 2026?

Based on GuruFocus' analysis, Divi's Laboratories stock appears to be overvalued. The current stock price of ₹6,753.50 is trading 0.4% above its estimated GF Value™ of ₹6,729.63. GuruFocus considers Divi's Laboratories to be Fairly Valued.

Key valuation signals for NSE:DIVISLAB:

  • Forward Dividend Yield %: 0.44%
  • GF Value™: ₹6,729.63 vs. price of ₹6,753.50 (0.4% above fair value)
  • GF Score™: 94/100 with 5 warning signs
  • Industry Position: 79% below the Drug Manufacturers median (#428 of 504)

No single metric tells the full story. See the NSE:DIVISLAB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Divi's Laboratories Business Description

Other Exchanges 532488:India
Address Cyber Hills, Divi Towers, 1-72/23(P)/DIVIS/303, Gachibowli, Hyderabad, TG, IND, 500032
Divi's Laboratories Ltd is a specialty and generic drug manufacturing company. It is engaged in the manufacture of Active Pharmaceutical ingredients (API), Intermediates, and Nutraceutical ingredients, with a predominance in exports. It also, through its custom synthesis, supports pharma companies for their patented products business from gram-scale requirements for clinical trials to launch, as well as late-life cycle management. Geographically, the company derives maximum revenue from Europe, and the rest from America, India, Asia (excluding India), and the Rest of the world.
94GF Score

Get the complete analysis for NSE:DIVISLAB

Forward Dividend Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹6,753.50
Price
₹6,729.63
GF Value